Paid Clinical Trials in Augusta, GA
As of September 2026, 179 paid clinical trials are recruiting in Augusta, Georgia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Augusta offers studies at sites including Augusta University Medical Center for conditions such as Acute Myeloid Leukemia, Ovarian Cancer, Sickle Cell Disease, Cervical Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Augusta
Trials by drug in Augusta
Filter results
Newly added in Augusta
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
166 clinical trials
A Study of Brenipatide in Adult Participants With Schizophrenia
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
DALY II USA/ MB-CART2019.1 for DLBCL
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Nectero EAST System Clinical Study
Galleri® in the Medicare Population.
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Top Research Study Locations in Augusta
Researchers run research studies in Augusta, GA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Augusta University Medical Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, B Acute Lymphoblastic Leukemia | 40 |
| Augusta University | Sickle Cell Disease, Focal Epilepsy, Advanced Endometrial Carcinoma | 33 |
| Georgia Cancer Center at Augusta University | Cervical Cancer, Ovarian Cancer, AML With Mutated NPM1 | 13 |
| Southeast Retina Center | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA), Geographic Atrophy Secondary to Age-related Macular Degeneration | 5 |
| Georgia Cancer Center | Ovarian Cancer, Previously Untreated Relapsed Refractory Acute Myeloid Leukemia, Solid Tumor | 4 |
| Southeast Retina Center, P.C. | Diabetic Retinal Disease, Epiretinal Membrane, Proliferative Diabetic Retinopathy (PDR) | 4 |
| Augusta Oncology Associates PC-D'Antignac | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 3 |
| Augusta Oncology Associates PC-Wheeler | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 3 |
| Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology | Osteo Arthritis Knee, Type 1 Diabetes, Whole Body Vibration | 3 |
| Aiyan Diabetes Center | Diabetes Mellitus, Type 2, Diabetic Foot Ulcer, Metabolic Syndrome | 2 |
| Ascentage Investigative | CML, CML, Chronic Phase, Chronic Myeloid Leukemia | 2 |
| Augusta University Georgia | Sickle Cell Disease | 2 |
| Augusta University Georgia Cancer Center | Breast Adenocarcinoma, Endometrial Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC) | 2 |
| Augusta University Health | Neuroblastoma | 2 |
| Augusta University, Georgia Cancer Center | Ependymoma, Glioblastoma, Medulloblastoma | 2 |
| Children's Hospital of Georgia | Failed or Difficult Intubation, Sequela, Intubation Complication, Intubation; Difficult | 2 |
| Piedmont Augusta Hospital | Acute Decompensated Heart Failure, Cardiovascular Diseases, Heart Diseases | 2 |
| Southeast Retina Center, PC | Diabetic Retinopathy, DR, Macular Edema | 2 |
| Southeastern Clinical Research Institute | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), End Stage Kidney Disease (ESRD) | 2 |
| Augusta University - Georgia Cancer Center | Acute Myeloid Leukaemia (AML), Fallopian Tube Cancer, Ovarian Cancer | 2 |
| AOS Surgery Center | Lumbar Spinal Stenosis | 1 |
| AU Medical Center | Degenerative Disc Disease, Neuropathic Pain, Spinal Cord Injuries | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Alliance Spine and Pain Ctrs | Lumbar Spinal Stenosis | 1 |
| Augusta Cancer Center | B Cell Precursor Type Acute Leukemia, Chronic Myeloid Leukemia, Leukemia, Myeloid, Chronic | 1 |
Active & Upcoming Studies in Augusta (2026)
Recruiting trials in Augusta grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (67 active studies)
- Trial of NLG802 Indoximod Prodrug Plus Temozolomide for Patients With Progressive Pediatric Brain Cancer · Phase 1 · Lumos Pharma
- Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia · Phase 3 · Quetzal Therapeutics
Neurology & pain (11 active studies)
- VETERANS AFFAIRS AUGUSTA · Companion IQ, Inc
- Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury · Phase 1 · EicOsis Human Health Inc.
Cardiovascular (8 active studies)
- Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258) · Phase 3 · Reprieve Cardiovascular, Inc
- Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure · Abbott Medical Devices
Eye & vision (8 active studies)
- Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration · VA Office of Research and Development
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Mental health & behavior (6 active studies)
- A Study of Brenipatide in Adult Participants With Schizophrenia · Phase 2 · Eli Lilly and Company
- Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD) · The University of Texas Health Science Center at San Antonio
Diabetes & metabolic (5 active studies)
- Assessing Obesity Related Risk Factors in Adult Population: A Genetic and Behavioral Study · Augusta University
- Lifestyle Intervention for Healthy Change · Augusta University
Pediatric (2 active studies)
Vaccines (1 active study)
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia · Phase 3 · UMC Utrecht
Common conditions studied in Augusta
- Acute Myeloid Leukemia (7 active studies)
- Ovarian Cancer (6 active studies)
- Sickle Cell Disease (5 active studies)
- Cervical Cancer (4 active studies)
- Malignant Solid Neoplasm (4 active studies)
- Solid Tumor (4 active studies)
Leading research sponsors in Augusta
- Augusta University
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Augusta?
There are approximately 179 recruiting clinical trials in Augusta, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Augusta pay participants?
Most recruiting trials in Augusta compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Augusta?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Augusta?
The most common conditions under active study in Augusta include Acute Myeloid Leukemia (7), Ovarian Cancer (6), Sickle Cell Disease (5), Cervical Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Augusta?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Augusta on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Augusta?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Augusta?
Recruiting research sites in Augusta include Augusta University Medical Center, Augusta University, Georgia Cancer Center at Augusta University, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Augusta right now?
The largest active categories in Augusta are Cancer & tumors (67), Neurology & pain (11), Cardiovascular (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.